Effect of doxapram on cerebral blood flow velocity in preterm infants

Neuropediatrics

Volumn 35, Issue 2, 2004, Pages 126-129

  Roll, Claudia ^a   Horsch, S ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Apnea of prematurity; Cerebral blood flow velocity; Doxapram

Indexed keywords

DOXAPRAM; METHYLXANTHINE; THEOPHYLLINE;

ANTERIOR CEREBRAL ARTERY; APNEA; ARTICLE; BIRTH WEIGHT; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN VASCULAR RESISTANCE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DIASTOLE; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG EFFECT; DRUG INDICATION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; SIDE EFFECT; SYSTOLE; WHITE MATTER;

ANTERIOR CEREBRAL ARTERY; APNEA; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; DOXAPRAM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; RESPIRATORY SYSTEM AGENTS;

EID: 2442530665     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-817904     Document Type: Article

References (28)

1. Barrington KJ, Finer NN, Peters KL, Barton J. Physiological effects of doxapram in idiopathic apnea of prematurity. J Pediatr 1986; 108: 125-129
2. Barrington KJ, Finer NN, Torok-Both G, Jamali F, Coutts RT. Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity. Pediatrics 1987; 80: 22-27
3. Blanchard PW, Aranda JV. Pharmacotherapy of respiratory control disorders. In: Beckerman RC, Brouillette RT, Hunt CE (Eds). Respiratory Control Disorders in Infants and Children. Baltimore: Williams & Wilkins, 1992: 352-370
4. De Villiers GS, Walele A, Van der Merwe PL, Kalis NN. Second-degree atrioventricular heart block after doxapram administration. J Pediatr 1998; 133: 149-150
5. Dani C, Bertini G, Reali MF, Tronchin M, Wiechmann L, Martelli E, Rubaltelli FE Brain hemodynamic changes in preterm infants after maintenance dose caffeine and aminophylline treatment. Biol Neonate 2000; 78: 27-32
6. Du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002; 15: 151-157
7. Govan JJ, Ohlsson A, Ryan ML, Myhr T, Fong K. Aminophylline and Doppler time-averaged mean velocity in the middle cerebral artery in preterm neonates. J Paediatr Child Health 1995; 31: 461-464
8. Hack M, Wilson-Costello D, Friedman H, Taylor GH, Schluchter M, Fanaroff AA. Neurodevelopment and predictors of outcomes of children with birth weights less than 1000 g. Arch Pediatr Adolesc Med 2000; 154: 725-231
9. Henderson-Smart DJ, Steer PA. Doxapram treatment for apnea in preterm infants. Cochrane Database Syst Rev 2001; 4: CD000074
10. Henderson-Smart DJ, Steer P. Doxapram versus methylxanthine for apnea in preterm infants. Cochrane Database Syst Rev 2000; 4: CD000075
11. Hoecker C, Nelle M, Poeschl J, Beedgen B, Linderkamp O. Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics 2002; 109: 784-787
12. Jacobs SE, O'Brian K, Inwood S, Kelly EN, Whyte HE. Outcome of infants 23-26 weeks gestation pre- and post-surfactant. Acta Paediatr 2000; 89: 959-965
13. Maillard C, Boutroy MJ, Fresson J, Barbe F, Hascoet JM. QT interval lengthening in premature infants treated with doxapram. Clin Pharmacol Ther 2001; 70: 540-545
14. Martin RJ, Fanaroff AA. Neonatal apnea, bradycardia, or desaturation: does it matter? J Pediatr 1998; 132: 758-759
15. McDonnell M, Ives NK, Hope PL Intravenous aminophylline and cerebral blood flow in preterm infants. Arch Dis Child 1992; 67: 416-418
16. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131: 549-554
17. Nelle M, Hoecker C, Linderkamp O. Effects of bolus tube feeding on cerebral blood flow velocity in neonates. Arch Dis Child Fetal Neonatal Ed 1997; 76: 54-56
18. Poets CF, Darraj S, Bohnhorst B. Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants. Biol Neonate 1999; 76: 207-213
19. Pryds O, Schneider S. Aminophylline reduces cerebral blood flow in stable, preterm infants without affecting the visual evoked potential. Eur J Pediatr 1991; 150: 366-369
20. Roll C, Hüning B, Kaunicke M, Krug J, Horsch S. Umbilical artery catheter blood sampling decreases cerebral blood volume and oxygenation in very low birthweight infants. Acta Paediatr 2000; 89: 862-866
21. Roll C, Knief J, Horsch S, Hanssler L. Effect of surfactant administration on cerebral haemodynamics and oxygenation in premature infants-a near infrared spectroscopy study. Neuropediatrics 2000; 31: 16-23
22. Roll C, Horsch S, Knief J, Husing J, Hanssler L. Comparison of effects of endotracheal suction and surfactant administration on hemodynamics and oxygenation of premature infants - a near infrared spectroscopy study. Z Geburtshilfe Neonatol 2001; 205: 104-109
23. Rosenkrantz TS, Oh W. Aminophylline reduces cerebral blood flow velocity in low-birth-weight infants. Am J Dis Child 1984; 138: 489-491
24. Schmidt B. Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway? J Pediatr 1999; 135: 526-528
25. Sreenan C, Etches PC, Demianczuk N, Robertson CM. Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea. J Pediatr 2001; 139: 832-837
26. Tay-Uyboco J, Kwiatkowski K, Cates DB, Seifert B, Hasan SU, Rigatto H. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity. Biol Neonate 1991; 69: 190-200
27. Uehara H, Yoshioka H, Nagai H, Ochiai R, Naito T, Hasegawa K et al. Doxapram accentuates white matter injury in neonatal rats following bilateral carotid artery occlusion. Neurosci Lett 2000; 281: 191-194
28. Wood NS, Marlow N, Costeloe K, Gibson AJ, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. N Engl J Med 2000; 343: 378-384